The global market for Point-of-care Infectious Disease Diagnostics was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Point of care diagnosis allows for early detection of diseases and can greatly impact the medical outcome of the disease treatment.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Point-of-care Infectious Disease Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Point-of-care Infectious Disease Diagnostics.

The Point-of-care Infectious Disease Diagnostics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Point-of-care Infectious Disease Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Point-of-care Infectious Disease Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Point-of-care Infectious Disease Diagnostics Market Report

Report Metric	Details
Report Name	Point-of-care Infectious Disease Diagnostics Market
CAGR	5%
Segment by Type	HIV POC Clostridium Difficile POC HBV POC Respiratory Syncytial Virus POC HPV POC Influenza/Flu POC HCV POC MRSA POC TB and Drug-Resistant TB POC
Segment by Application	Hospitals Clinics Home Assisted Living Healthcare Facilities Laboratories Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Thermo Fisher Scientific, Abbott, Calypte Biomedical, Chembio Diagnostic Systems, Meridian Bioscience, MedMira, Trinity Biotech, Sekisui Diagnostics, OraSure Technologies, Quidel
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Point-of-care Infectious Disease Diagnostics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Point-of-care Infectious Disease Diagnostics Market report?

Ans: The main players in the Point-of-care Infectious Disease Diagnostics Market are Thermo Fisher Scientific, Abbott, Calypte Biomedical, Chembio Diagnostic Systems, Meridian Bioscience, MedMira, Trinity Biotech, Sekisui Diagnostics, OraSure Technologies, Quidel

What are the Application segmentation covered in the Point-of-care Infectious Disease Diagnostics Market report?

Ans: The Applications covered in the Point-of-care Infectious Disease Diagnostics Market report are Hospitals, Clinics, Home, Assisted Living Healthcare Facilities, Laboratories, Others

What are the Type segmentation covered in the Point-of-care Infectious Disease Diagnostics Market report?

Ans: The Types covered in the Point-of-care Infectious Disease Diagnostics Market report are HIV POC, Clostridium Difficile POC, HBV POC, Respiratory Syncytial Virus POC, HPV POC, Influenza/Flu POC, HCV POC, MRSA POC, TB and Drug-Resistant TB POC

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Point-of-care Infectious Disease Diagnostics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 HIV POC

1.2.3 Clostridium Difficile POC

1.2.4 HBV POC

1.2.5 Respiratory Syncytial Virus POC

1.2.6 HPV POC

1.2.7 Influenza/Flu POC

1.2.8 HCV POC

1.2.9 MRSA POC

1.2.10 TB and Drug-Resistant TB POC

1.3 Market by Application

1.3.1 Global Point-of-care Infectious Disease Diagnostics Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Home

1.3.5 Assisted Living Healthcare Facilities

1.3.6 Laboratories

1.3.7 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Point-of-care Infectious Disease Diagnostics Market Perspective (2020-2031)

2.2 Global Point-of-care Infectious Disease Diagnostics Growth Trends by Region

2.2.1 Global Point-of-care Infectious Disease Diagnostics Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Point-of-care Infectious Disease Diagnostics Historic Market Size by Region (2020-2025)

2.2.3 Point-of-care Infectious Disease Diagnostics Forecasted Market Size by Region (2026-2031)

2.3 Point-of-care Infectious Disease Diagnostics Market Dynamics

2.3.1 Point-of-care Infectious Disease Diagnostics Industry Trends

2.3.2 Point-of-care Infectious Disease Diagnostics Market Drivers

2.3.3 Point-of-care Infectious Disease Diagnostics Market Challenges

2.3.4 Point-of-care Infectious Disease Diagnostics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Point-of-care Infectious Disease Diagnostics Players by Revenue

3.1.1 Global Top Point-of-care Infectious Disease Diagnostics Players by Revenue (2020-2025)

3.1.2 Global Point-of-care Infectious Disease Diagnostics Revenue Market Share by Players (2020-2025)

3.2 Global Point-of-care Infectious Disease Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Point-of-care Infectious Disease Diagnostics Revenue

3.4 Global Point-of-care Infectious Disease Diagnostics Market Concentration Ratio

3.4.1 Global Point-of-care Infectious Disease Diagnostics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Point-of-care Infectious Disease Diagnostics Revenue in 2024

3.5 Global Key Players of Point-of-care Infectious Disease Diagnostics Head office and Area Served

3.6 Global Key Players of Point-of-care Infectious Disease Diagnostics, Product and Application

3.7 Global Key Players of Point-of-care Infectious Disease Diagnostics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Point-of-care Infectious Disease Diagnostics Breakdown Data by Type

4.1 Global Point-of-care Infectious Disease Diagnostics Historic Market Size by Type (2020-2025)

4.2 Global Point-of-care Infectious Disease Diagnostics Forecasted Market Size by Type (2026-2031)

5 Point-of-care Infectious Disease Diagnostics Breakdown Data by Application

5.1 Global Point-of-care Infectious Disease Diagnostics Historic Market Size by Application (2020-2025)

5.2 Global Point-of-care Infectious Disease Diagnostics Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Point-of-care Infectious Disease Diagnostics Market Size (2020-2031)

6.2 North America Point-of-care Infectious Disease Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Point-of-care Infectious Disease Diagnostics Market Size by Country (2020-2025)

6.4 North America Point-of-care Infectious Disease Diagnostics Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Point-of-care Infectious Disease Diagnostics Market Size (2020-2031)

7.2 Europe Point-of-care Infectious Disease Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Point-of-care Infectious Disease Diagnostics Market Size by Country (2020-2025)

7.4 Europe Point-of-care Infectious Disease Diagnostics Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Point-of-care Infectious Disease Diagnostics Market Size (2020-2031)

8.2 Asia-Pacific Point-of-care Infectious Disease Diagnostics Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Point-of-care Infectious Disease Diagnostics Market Size by Region (2020-2025)

8.4 Asia-Pacific Point-of-care Infectious Disease Diagnostics Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Point-of-care Infectious Disease Diagnostics Market Size (2020-2031)

9.2 Latin America Point-of-care Infectious Disease Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Point-of-care Infectious Disease Diagnostics Market Size by Country (2020-2025)

9.4 Latin America Point-of-care Infectious Disease Diagnostics Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size (2020-2031)

10.2 Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size by Country (2020-2025)

10.4 Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Thermo Fisher Scientific

11.1.1 Thermo Fisher Scientific Company Details

11.1.2 Thermo Fisher Scientific Business Overview

11.1.3 Thermo Fisher Scientific Point-of-care Infectious Disease Diagnostics Introduction

11.1.4 Thermo Fisher Scientific Revenue in Point-of-care Infectious Disease Diagnostics Business (2020-2025)

11.1.5 Thermo Fisher Scientific Recent Development

11.2 Abbott

11.2.1 Abbott Company Details

11.2.2 Abbott Business Overview

11.2.3 Abbott Point-of-care Infectious Disease Diagnostics Introduction

11.2.4 Abbott Revenue in Point-of-care Infectious Disease Diagnostics Business (2020-2025)

11.2.5 Abbott Recent Development

11.3 Calypte Biomedical

11.3.1 Calypte Biomedical Company Details

11.3.2 Calypte Biomedical Business Overview

11.3.3 Calypte Biomedical Point-of-care Infectious Disease Diagnostics Introduction

11.3.4 Calypte Biomedical Revenue in Point-of-care Infectious Disease Diagnostics Business (2020-2025)

11.3.5 Calypte Biomedical Recent Development

11.4 Chembio Diagnostic Systems

11.4.1 Chembio Diagnostic Systems Company Details

11.4.2 Chembio Diagnostic Systems Business Overview

11.4.3 Chembio Diagnostic Systems Point-of-care Infectious Disease Diagnostics Introduction

11.4.4 Chembio Diagnostic Systems Revenue in Point-of-care Infectious Disease Diagnostics Business (2020-2025)

11.4.5 Chembio Diagnostic Systems Recent Development

11.5 Meridian Bioscience

11.5.1 Meridian Bioscience Company Details

11.5.2 Meridian Bioscience Business Overview

11.5.3 Meridian Bioscience Point-of-care Infectious Disease Diagnostics Introduction

11.5.4 Meridian Bioscience Revenue in Point-of-care Infectious Disease Diagnostics Business (2020-2025)

11.5.5 Meridian Bioscience Recent Development

11.6 MedMira

11.6.1 MedMira Company Details

11.6.2 MedMira Business Overview

11.6.3 MedMira Point-of-care Infectious Disease Diagnostics Introduction

11.6.4 MedMira Revenue in Point-of-care Infectious Disease Diagnostics Business (2020-2025)

11.6.5 MedMira Recent Development

11.7 Trinity Biotech

11.7.1 Trinity Biotech Company Details

11.7.2 Trinity Biotech Business Overview

11.7.3 Trinity Biotech Point-of-care Infectious Disease Diagnostics Introduction

11.7.4 Trinity Biotech Revenue in Point-of-care Infectious Disease Diagnostics Business (2020-2025)

11.7.5 Trinity Biotech Recent Development

11.8 Sekisui Diagnostics

11.8.1 Sekisui Diagnostics Company Details

11.8.2 Sekisui Diagnostics Business Overview

11.8.3 Sekisui Diagnostics Point-of-care Infectious Disease Diagnostics Introduction

11.8.4 Sekisui Diagnostics Revenue in Point-of-care Infectious Disease Diagnostics Business (2020-2025)

11.8.5 Sekisui Diagnostics Recent Development

11.9 OraSure Technologies

11.9.1 OraSure Technologies Company Details

11.9.2 OraSure Technologies Business Overview

11.9.3 OraSure Technologies Point-of-care Infectious Disease Diagnostics Introduction

11.9.4 OraSure Technologies Revenue in Point-of-care Infectious Disease Diagnostics Business (2020-2025)

11.9.5 OraSure Technologies Recent Development

11.10 Quidel

11.10.1 Quidel Company Details

11.10.2 Quidel Business Overview

11.10.3 Quidel Point-of-care Infectious Disease Diagnostics Introduction

11.10.4 Quidel Revenue in Point-of-care Infectious Disease Diagnostics Business (2020-2025)

11.10.5 Quidel Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Thermo Fisher Scientific

Abbott

Calypte Biomedical

Chembio Diagnostic Systems

List of Tables

Table 1. Global Point-of-care Infectious Disease Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of HIV POC

Table 3. Key Players of Clostridium Difficile POC

Table 4. Key Players of HBV POC

Table 5. Key Players of Respiratory Syncytial Virus POC

Table 6. Key Players of HPV POC

Table 7. Key Players of Influenza/Flu POC

Table 8. Key Players of HCV POC

Table 9. Global Point-of-care Infectious Disease Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 10. Global Point-of-care Infectious Disease Diagnostics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 11. Global Point-of-care Infectious Disease Diagnostics Market Size by Region (2020-2025) & (US$ Million)

Table 12. Global Point-of-care Infectious Disease Diagnostics Market Share by Region (2020-2025)

Table 13. Global Point-of-care Infectious Disease Diagnostics Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 14. Global Point-of-care Infectious Disease Diagnostics Market Share by Region (2026-2031)

Table 15. Point-of-care Infectious Disease Diagnostics Market Trends

Table 16. Point-of-care Infectious Disease Diagnostics Market Drivers

Table 17. Point-of-care Infectious Disease Diagnostics Market Challenges

Table 18. Point-of-care Infectious Disease Diagnostics Market Restraints

Table 19. Global Point-of-care Infectious Disease Diagnostics Revenue by Players (2020-2025) & (US$ Million)

Table 20. Global Point-of-care Infectious Disease Diagnostics Market Share by Players (2020-2025)

Table 21. Global Top Point-of-care Infectious Disease Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Point-of-care Infectious Disease Diagnostics as of 2024)

Table 22. Ranking of Global Top Point-of-care Infectious Disease Diagnostics Companies by Revenue (US$ Million) in 2024

Table 23. Global 5 Largest Players Market Share by Point-of-care Infectious Disease Diagnostics Revenue (CR5 and HHI) & (2020-2025)

Table 24. Global Key Players of Point-of-care Infectious Disease Diagnostics, Headquarters and Area Served

Table 25. Global Key Players of Point-of-care Infectious Disease Diagnostics, Product and Application

Table 26. Global Key Players of Point-of-care Infectious Disease Diagnostics, Date of Enter into This Industry

Table 27. Mergers & Acquisitions, Expansion Plans

Table 28. Global Point-of-care Infectious Disease Diagnostics Market Size by Type (2020-2025) & (US$ Million)

Table 29. Global Point-of-care Infectious Disease Diagnostics Revenue Market Share by Type (2020-2025)

Table 30. Global Point-of-care Infectious Disease Diagnostics Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 31. Global Point-of-care Infectious Disease Diagnostics Revenue Market Share by Type (2026-2031)

Table 32. Global Point-of-care Infectious Disease Diagnostics Market Size by Application (2020-2025) & (US$ Million)

Table 33. Global Point-of-care Infectious Disease Diagnostics Revenue Market Share by Application (2020-2025)

Table 34. Global Point-of-care Infectious Disease Diagnostics Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 35. Global Point-of-care Infectious Disease Diagnostics Revenue Market Share by Application (2026-2031)

Table 36. North America Point-of-care Infectious Disease Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. North America Point-of-care Infectious Disease Diagnostics Market Size by Country (2020-2025) & (US$ Million)

Table 38. North America Point-of-care Infectious Disease Diagnostics Market Size by Country (2026-2031) & (US$ Million)

Table 39. Europe Point-of-care Infectious Disease Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 40. Europe Point-of-care Infectious Disease Diagnostics Market Size by Country (2020-2025) & (US$ Million)

Table 41. Europe Point-of-care Infectious Disease Diagnostics Market Size by Country (2026-2031) & (US$ Million)

Table 42. Asia-Pacific Point-of-care Infectious Disease Diagnostics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 43. Asia-Pacific Point-of-care Infectious Disease Diagnostics Market Size by Region (2020-2025) & (US$ Million)

Table 44. Asia-Pacific Point-of-care Infectious Disease Diagnostics Market Size by Region (2026-2031) & (US$ Million)

Table 45. Latin America Point-of-care Infectious Disease Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Latin America Point-of-care Infectious Disease Diagnostics Market Size by Country (2020-2025) & (US$ Million)

Table 47. Latin America Point-of-care Infectious Disease Diagnostics Market Size by Country (2026-2031) & (US$ Million)

Table 48. Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 49. Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size by Country (2020-2025) & (US$ Million)

Table 50. Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size by Country (2026-2031) & (US$ Million)

Table 51. Thermo Fisher Scientific Company Details

Table 52. Thermo Fisher Scientific Business Overview

Table 53. Thermo Fisher Scientific Point-of-care Infectious Disease Diagnostics Product

Table 54. Thermo Fisher Scientific Revenue in Point-of-care Infectious Disease Diagnostics Business (2020-2025) & (US$ Million)

Table 55. Thermo Fisher Scientific Recent Development

Table 56. Abbott Company Details

Table 57. Abbott Business Overview

Table 58. Abbott Point-of-care Infectious Disease Diagnostics Product

Table 59. Abbott Revenue in Point-of-care Infectious Disease Diagnostics Business (2020-2025) & (US$ Million)

Table 60. Abbott Recent Development

Table 61. Calypte Biomedical Company Details

Table 62. Calypte Biomedical Business Overview

Table 63. Calypte Biomedical Point-of-care Infectious Disease Diagnostics Product

Table 64. Calypte Biomedical Revenue in Point-of-care Infectious Disease Diagnostics Business (2020-2025) & (US$ Million)

Table 65. Calypte Biomedical Recent Development

Table 66. Chembio Diagnostic Systems Company Details

Table 67. Chembio Diagnostic Systems Business Overview

Table 68. Chembio Diagnostic Systems Point-of-care Infectious Disease Diagnostics Product

Table 69. Chembio Diagnostic Systems Revenue in Point-of-care Infectious Disease Diagnostics Business (2020-2025) & (US$ Million)

Table 70. Chembio Diagnostic Systems Recent Development

Table 71. Meridian Bioscience Company Details

Table 72. Meridian Bioscience Business Overview

Table 73. Meridian Bioscience Point-of-care Infectious Disease Diagnostics Product

Table 74. Meridian Bioscience Revenue in Point-of-care Infectious Disease Diagnostics Business (2020-2025) & (US$ Million)

Table 75. Meridian Bioscience Recent Development

Table 76. MedMira Company Details

Table 77. MedMira Business Overview

Table 78. MedMira Point-of-care Infectious Disease Diagnostics Product

Table 79. MedMira Revenue in Point-of-care Infectious Disease Diagnostics Business (2020-2025) & (US$ Million)

Table 80. MedMira Recent Development

Table 81. Trinity Biotech Company Details

Table 82. Trinity Biotech Business Overview

Table 83. Trinity Biotech Point-of-care Infectious Disease Diagnostics Product

Table 84. Trinity Biotech Revenue in Point-of-care Infectious Disease Diagnostics Business (2020-2025) & (US$ Million)

Table 85. Trinity Biotech Recent Development

Table 86. Sekisui Diagnostics Company Details

Table 87. Sekisui Diagnostics Business Overview

Table 88. Sekisui Diagnostics Point-of-care Infectious Disease Diagnostics Product

Table 89. Sekisui Diagnostics Revenue in Point-of-care Infectious Disease Diagnostics Business (2020-2025) & (US$ Million)

Table 90. Sekisui Diagnostics Recent Development

Table 91. OraSure Technologies Company Details

Table 92. OraSure Technologies Business Overview

Table 93. OraSure Technologies Point-of-care Infectious Disease Diagnostics Product

Table 94. OraSure Technologies Revenue in Point-of-care Infectious Disease Diagnostics Business (2020-2025) & (US$ Million)

Table 95. OraSure Technologies Recent Development

Table 96. Quidel Company Details

Table 97. Quidel Business Overview

Table 98. Quidel Point-of-care Infectious Disease Diagnostics Product

Table 99. Quidel Revenue in Point-of-care Infectious Disease Diagnostics Business (2020-2025) & (US$ Million)

Table 100. Quidel Recent Development

Table 101. Research Programs/Design for This Report

Table 102. Key Data Information from Secondary Sources

Table 103. Key Data Information from Primary Sources

Table 104. Authors List of This Report

List of Figures

Figure 1. Point-of-care Infectious Disease Diagnostics Picture

Figure 2. Global Point-of-care Infectious Disease Diagnostics Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Point-of-care Infectious Disease Diagnostics Market Share by Type: 2024 VS 2031

Figure 4. HIV POC Features

Figure 5. Clostridium Difficile POC Features

Figure 6. HBV POC Features

Figure 7. Respiratory Syncytial Virus POC Features

Figure 8. HPV POC Features

Figure 9. Influenza/Flu POC Features

Figure 10. HCV POC Features

Figure 11. MRSA POC Features

Figure 12. TB and Drug-Resistant TB POC Features

Figure 13. Global Point-of-care Infectious Disease Diagnostics Market Size by Application (2020-2031) & (US$ Million)

Figure 14. Global Point-of-care Infectious Disease Diagnostics Market Share by Application: 2024 VS 2031

Figure 15. Hospitals Case Studies

Figure 16. Clinics Case Studies

Figure 17. Home Case Studies

Figure 18. Assisted Living Healthcare Facilities Case Studies

Figure 19. Laboratories Case Studies

Figure 20. Others Case Studies

Figure 21. Point-of-care Infectious Disease Diagnostics Report Years Considered

Figure 22. Global Point-of-care Infectious Disease Diagnostics Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 23. Global Point-of-care Infectious Disease Diagnostics Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 24. Global Point-of-care Infectious Disease Diagnostics Market Share by Region: 2024 VS 2031

Figure 25. Global Point-of-care Infectious Disease Diagnostics Market Share by Players in 2024

Figure 26. Global Top Point-of-care Infectious Disease Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Point-of-care Infectious Disease Diagnostics as of 2024)

Figure 27. The Top 10 and 5 Players Market Share by Point-of-care Infectious Disease Diagnostics Revenue in 2024

Figure 28. North America Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. North America Point-of-care Infectious Disease Diagnostics Market Share by Country (2020-2031)

Figure 30. United States Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Canada Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Europe Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Europe Point-of-care Infectious Disease Diagnostics Market Share by Country (2020-2031)

Figure 34. Germany Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. France Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. U.K. Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Italy Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Russia Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Nordic Countries Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Asia-Pacific Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Asia-Pacific Point-of-care Infectious Disease Diagnostics Market Share by Region (2020-2031)

Figure 42. China Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Japan Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. South Korea Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Southeast Asia Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. India Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Australia Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Latin America Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Latin America Point-of-care Infectious Disease Diagnostics Market Share by Country (2020-2031)

Figure 50. Mexico Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. Brazil Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 52. Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 53. Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Share by Country (2020-2031)

Figure 54. Turkey Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 55. Saudi Arabia Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 56. UAE Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 57. Thermo Fisher Scientific Revenue Growth Rate in Point-of-care Infectious Disease Diagnostics Business (2020-2025)

Figure 58. Abbott Revenue Growth Rate in Point-of-care Infectious Disease Diagnostics Business (2020-2025)

Figure 59. Calypte Biomedical Revenue Growth Rate in Point-of-care Infectious Disease Diagnostics Business (2020-2025)

Figure 60. Chembio Diagnostic Systems Revenue Growth Rate in Point-of-care Infectious Disease Diagnostics Business (2020-2025)

Figure 61. Meridian Bioscience Revenue Growth Rate in Point-of-care Infectious Disease Diagnostics Business (2020-2025)

Figure 62. MedMira Revenue Growth Rate in Point-of-care Infectious Disease Diagnostics Business (2020-2025)

Figure 63. Trinity Biotech Revenue Growth Rate in Point-of-care Infectious Disease Diagnostics Business (2020-2025)

Figure 64. Sekisui Diagnostics Revenue Growth Rate in Point-of-care Infectious Disease Diagnostics Business (2020-2025)

Figure 65. OraSure Technologies Revenue Growth Rate in Point-of-care Infectious Disease Diagnostics Business (2020-2025)

Figure 66. Quidel Revenue Growth Rate in Point-of-care Infectious Disease Diagnostics Business (2020-2025)

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions